2021
DOI: 10.1097/mot.0000000000000944
|View full text |Cite
|
Sign up to set email alerts
|

Novel biomarkers of chronic lung allograft dysfunction: is there anything reliable?

Abstract: Purpose of reviewChronic lung allograft dysfunction (CLAD) remains a major barrier preventing long-term survival following lung transplantation. As our clinical knowledge regarding its definition and presentation has significantly improved over the last years, adequate biomarkers to predict development of CLAD, phenotype of CLAD or prognosis post-CLAD diagnosis are definitely needed. Recent findingsRadiological and physiological markers are gradually entering routine clinical practice. In-depth investigation o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
6
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(6 citation statements)
references
References 52 publications
0
6
0
Order By: Relevance
“…Six studies are discussed which successively addressed the activation of dendritic cells ( 19 ), secretion of matrix metaloproteinase-9 by activated T cells ( 22 , 24 ), and three for the blood of T and B subpopulations to predict BOS ( 26 , 27 , 31 ). All these studies explored mechanisms and finally immune biomarkers as candidates are able to predict CLAD after LT ( 3 , 12 , 13 , 42 ).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Six studies are discussed which successively addressed the activation of dendritic cells ( 19 ), secretion of matrix metaloproteinase-9 by activated T cells ( 22 , 24 ), and three for the blood of T and B subpopulations to predict BOS ( 26 , 27 , 31 ). All these studies explored mechanisms and finally immune biomarkers as candidates are able to predict CLAD after LT ( 3 , 12 , 13 , 42 ).…”
Section: Discussionmentioning
confidence: 99%
“…Although the pathophysiological mechanisms and the risk factors implicated in BOS and RAS are far from being fully elucidated, literature provides increasing evidence and novel insights, especially regarding auto-antibodies ( 4 , 6 , 10 , 11 ). Identification of risk factors associated with specific CLAD phenotypes together with relevant biomarkers ( 12 , 13 ) is of crucial importance as it may assist patient risk stratification, optimize follow-up, and allow prevention and early intervention for potentially modifiable factors. In the field of kidney transplantation, this objective has been reached in 2021 by an international consortium ( 14 ).…”
Section: Introductionmentioning
confidence: 99%
“…Though TUS might be regarded as a novel modality for clinical guidance in the management of lung transplantation (LTx), its wide range of applications within the different fields of LTx has received increased recognition [ 13 , 14 ]. However, due to LTx being a rare condition, the evidence for TUS use in all stages of LTx is restricted to a few studies that are very often based on observations from a limited number of lung transplant recipients.…”
Section: Introductionmentioning
confidence: 99%
“…11 Other proposed methods include the multiple breath washout (MBW) technique, lung magnetic resonance imaging (MRI), infant/preschool spirometric methods, and biomarkers like cell-free DNA have been proposed. [12][13][14][15] Regardless, despite limitations to the current adultfocused definition of CLAD/Bronchiolitis obliterans syndrome (BOS), there is no pediatric-specific consensus on CLAD detection and monitoring strategies. We sought to determine CLAD detection and monitoring practices at pediatric lung transplant programs, aiming to better understand international practices and potential variability in approaches to testing for CLAD in pediatrics.…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, supplemental or novel methods for CLAD diagnosis have been proposed, especially for younger children, including chest computed tomography (CT) imaging and histopathology from lung tissue biopsies 11 . Other proposed methods include the multiple breath washout (MBW) technique, lung magnetic resonance imaging (MRI), infant/preschool spirometric methods, and biomarkers like cell‐free DNA have been proposed 12–15 . Regardless, despite limitations to the current adult‐focused definition of CLAD/Bronchiolitis obliterans syndrome (BOS), there is no pediatric‐specific consensus on CLAD detection and monitoring strategies.…”
Section: Introductionmentioning
confidence: 99%